Characteristics | Baseline (n = 22) | 6-month (n = 22) | P-value |
---|---|---|---|
Age (years) | |||
 Mean ± SD | 62.41 ± 8.13 | – | – |
 Range | 43 ~ 78 | – | – |
Gender | |||
 Male, n (%) | 5 (22.7) | – | – |
 Female, n (%) | 17 (77.3) | – | – |
Side | |||
 Right, n (%) | 12 (54.6) | – | – |
 Left, n (%) | 10 (45.4) | – | – |
Duration of symptoms (months) | |||
 Mean ± SD | 7.77 ± 3.09 | – | – |
 Range | 3 ~ 14 | – | – |
IMH stage | |||
 Stage 3 | 16 | – | – |
 Stage 4 | 6 | – | – |
MD of IMH (μm) | 592.12 ± 165.76 | – | – |
BD of IMH (μm) | 1008.04 ± 262.72 | – | – |
BCVA (logMAR)* | |||
 Mean ± SD | 1.10 ± 0.33 | 0.67 ± 0.32 | P < 0.001 |
Macular sensitivity (dB)# | |||
 Overall (within 10o) | 8.58 ± 3.05 | 11.55 ± 2.72 | t = 7.176, P < 0.001 |
 Peri-foveal (2o to 10o) | 9.88 ± 3.48 | 13.07 ± 2.22 | t = 5.465, P < 0.001 |
 Foveal (within 2o) | 3.39 ± 1.98 | 7.55 ± 2.92 | t = 10.700, P < 0.001 |
Foveal fixation (%)# | 65.64 ± 17.28 | 78.59 ± 13.00 | t = 7.125, P < 0.001 |